Literature DB >> 23666666

Development of IgG4-related disease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma.

Takeki Mitsui1, Akihiko Yokohama, Hiromi Koiso, Takuma Ishizaki, Hideki Uchiumi, Takayuki Saitoh, Hiroshi Handa, Junko Hirato, Masamitsu Karasawa, Hirokazu Murakami, Masaru Kojima, Yoshihisa Nojima, Norifumi Tsukamoto.   

Abstract

Reported is a rare case IgG4-related disease that developed 10 years after combination chemotherapy for non-Hodgkin lymphoma. A 59-year-old Japanese man with longstanding bronchial asthma was referred to our hospital for bilateral hilar lymph node enlargement. The initial diagnosis was diffuse large B cell lymphoma (DLBCL) by supraclavicular lymph node biopsy. Serum IgG was high (4550 mg/dL) at diagnosis. The patient achieved complete response following six cycles of combination chemotherapy. Ten years later, bilateral submaxillary gland swelling was observed. Serum IgG and IgG4 were 2909 and 1470 mg/dL, respectively. The patient was diagnosed with IgG4-related disease by submandibular lymph node biopsy. Due to the difficulty in distinguishing IgG4-related disease from DLBCL through imaging findings alone, pathological confirmation of such lesions by biopsy is mandatory before proceeding to treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23666666     DOI: 10.1007/s12185-013-1359-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  32 in total

Review 1.  Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.

Authors:  Karin Ekström Smedby; Eva Baecklund; Johan Askling
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

2.  Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related Sclerosing disease?

Authors:  Wah Cheuk; Hunter K L Yuen; John K C Chan
Journal:  Am J Surg Pathol       Date:  2007-04       Impact factor: 6.394

3.  Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.

Authors:  Y Masaki; L Dong; N Kurose; K Kitagawa; Y Morikawa; M Yamamoto; H Takahashi; Y Shinomura; K Imai; T Saeki; A Azumi; S Nakada; E Sugiyama; S Matsui; T Origuchi; S Nishiyama; I Nishimori; T Nojima; K Yamada; M Kawano; Y Zen; M Kaneko; K Miyazaki; K Tsubota; K Eguchi; K Tomoda; T Sawaki; T Kawanami; M Tanaka; T Fukushima; S Sugai; H Umehara
Journal:  Ann Rheum Dis       Date:  2008-08-13       Impact factor: 19.103

4.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

5.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

6.  Three cases of bronchial asthma preceding IgG4-related autoimmune pancreatitis.

Authors:  Satoru Ito; Shigeru B H Ko; Masataka Morioka; Kazuyoshi Imaizumi; Masashi Kondo; Nobumasa Mizuno; Yoshinori Hasegawa
Journal:  Allergol Int       Date:  2011-12-25       Impact factor: 5.836

7.  Lymphadenopathy of IgG4-related sclerosing disease.

Authors:  Wah Cheuk; Hunter K L Yuen; Stephenie Y Y Chu; Edmond K W Chiu; L K Lam; John K C Chan
Journal:  Am J Surg Pathol       Date:  2008-05       Impact factor: 6.394

Review 8.  Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Atsutake Okamoto
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

9.  Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis.

Authors:  Hideaki Hamano; Norikazu Arakura; Takashi Muraki; Yayoi Ozaki; Kendo Kiyosawa; Shigeyuki Kawa
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

10.  Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease.

Authors:  Wah Cheuk; Hunter K L Yuen; Alexander C L Chan; Lee-Yung Shih; Tseng-Tong Kuo; Ming-Wai Ma; Yan-Fai Lo; Wai-Kong Chan; John K C Chan
Journal:  Am J Surg Pathol       Date:  2008-08       Impact factor: 6.394

View more
  5 in total

1.  Role of IgG4 serology in identifying common orbital lymphoproliferative disorders.

Authors:  Jing Li; Jian-Min Ma; Xin Ge
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

2.  Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease.

Authors:  Ryan C W Ho; Thomas S Y Chan; Rex Au-Yeung; Karen H K Tang; Yu-Yan Hwang; Eric Tse; Yok-Lam Kwong
Journal:  Ann Hematol       Date:  2021-11-12       Impact factor: 3.673

3.  Occurrence of anaplastic large cell lymphoma following IgG4-related autoimmune pancreatitis and cholecystitis and diffuse large B-cell lymphoma.

Authors:  Mitsuaki Ishida; Keiko Hodohara; Keiko Yoshida; Akiko Kagotani; Muneo Iwai; Miyuki Yoshii; Hiroko Okuno; Akiko Horinouchi; Ryota Nakanishi; Ayumi Harada; Takashi Yoshida; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

Review 4.  Diffuse Large B-Cell Lymphoma 18 Years After Bilateral Lacrimal Gland IgG4-Related Disease: Case Report and Literature Review.

Authors:  Toshihiko Matsuo; Takehiro Tanaka; Kenji Notohara; Kazuya Okada
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

5.  IgG4-related Disease with a Cardiac Mass.

Authors:  Ikuko Matsumura; Takeki Mitsui; Kenichi Tahara; Hiroaki Shimizu; Kunio Yanagisawa; Takuma Ishizaki; Hiromi Koiso; Makiko Takizawa; Akihiko Yokohama; Takayuki Saitoh; Junko Hirato; Hirokazu Murakami; Hiroshi Handa; Norifumi Tsukamoto
Journal:  Intern Med       Date:  2020-01-17       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.